Jeremy Grantham's portfolio
In the Q2 2026 13F, filed August 13, 2026, GMO reported 661 US stock positions worth $44.4B. The largest was Microsoft (MSFT) at 5.7% of the portfolio. New positions: Philip Morris International (PM), Qorvo (QRVO) and Allied Gold (AAUC). Added to: Microsoft (MSFT) and Meta Platforms (META). The Q3 2026 13F is due by November 14, 2026.
What changed in Q2 2026
Compared with the previous 13F. Values are as reported at quarter end. How to read a 13F.
New positions
- Philip Morris InternationalPM$140M
- QorvoQRVO$29M
- Allied GoldAAUC$27M
- Nextera EnergyNEE$19M
- Caesars EntertainmentCZR$19M
- Apogee TherapeuticsAPGE$18M
- MedpaceMEDP$18M
- Primoris ServicesPRIM$14M
- MoodysMCO$13M
- CelsiusCELH$11M
Added to
- MicrosoftMSFT$2.5B
- Meta PlatformsMETA$1.9B
- Thermo Fisher ScientificTMO$1.4B
- KLAKLAC$1.2B
- VisaV$1.1B
- NVIDIANVDA$935M
- MastercardMA$934M
- NetflixNFLX$739M
- SalesforceCRM$694M
- Uber TechnologiesUBER$533M
Trimmed
- Lam ResearchLRCX$2.4B
- AlphabetGOOGL$2.2B
- AppleAAPL$2.0B
- Johnson & JohnsonJNJ$1.8B
- Amazon.comAMZN$1.5B
- Texas InstrumentsTXN$1.4B
- BroadcomAVGO$1.2B
- UnitedHealth GroupUNH$1.2B
- U.S. BancorpUSB$899M
- Eli Lilly and CompanyLLY$892M
Sold out
None this quarter.
Holdings
661 US-listed positions in the Q2 2026 13F, largest first (top 50 shown; all of them in Investingly).
| Stock | % of portfolio | Value | Shares | Last quarter |
|---|---|---|---|---|
| MicrosoftMSFT | 5.73% | $2.5B | 6,816,326 | Added |
| Lam ResearchLRCX | 5.33% | $2.4B | 5,464,726 | Trimmed |
| AlphabetGOOGL | 4.94% | $2.2B | 6,132,636 | Trimmed |
| AppleAAPL | 4.46% | $2.0B | 6,848,782 | Trimmed |
| Meta PlatformsMETA | 4.37% | $1.9B | 3,446,717 | Added |
| Johnson & JohnsonJNJ | 4.07% | $1.8B | 7,110,133 | Trimmed |
| Amazon.comAMZN | 3.30% | $1.5B | 6,136,926 | Trimmed |
| Texas InstrumentsTXN | 3.14% | $1.4B | 4,674,406 | Trimmed |
| Thermo Fisher ScientificTMO | 3.09% | $1.4B | 2,739,191 | Added |
| BroadcomAVGO | 2.78% | $1.2B | 3,267,040 | Trimmed |
| KLAKLAC | 2.65% | $1.2B | 3,893,893 | Added |
| UnitedHealth GroupUNH | 2.65% | $1.2B | 2,825,022 | Trimmed |
| VisaV | 2.56% | $1.1B | 3,318,194 | Added |
| NVIDIANVDA | 2.11% | $935M | 4,671,972 | Added |
| MastercardMA | 2.10% | $934M | 1,818,743 | Added |
| U.S. BancorpUSB | 2.03% | $899M | 14,885,214 | Trimmed |
| Eli Lilly and CompanyLLY | 2.01% | $892M | 743,966 | Trimmed |
| Merck & CompanyMRK | 1.96% | $872M | 6,785,008 | Trimmed |
| Abbott LaboratoriesABT | 1.80% | $798M | 8,794,077 | Trimmed |
| NetflixNFLX | 1.67% | $739M | 10,350,004 | Added |
| Cigna GroupCI | 1.60% | $710M | 2,577,075 | Trimmed |
| SalesforceCRM | 1.56% | $694M | 4,427,933 | Added |
| Coca-ColaKO | 1.50% | $668M | 8,219,620 | Trimmed |
| Elevance HealthELV | 1.47% | $654M | 1,691,671 | Trimmed |
| Tjx Cos Inc New | 1.26% | $557M | 3,679,188 | Held |
| Constellation BrandsSTZ | 1.25% | $556M | 3,998,425 | Trimmed |
| Uber TechnologiesUBER | 1.20% | $533M | 7,389,658 | Added |
| Accenture Plc Ireland | 1.12% | $496M | 3,984,233 | Held |
| Intuitive SurgicalISRG | 1.10% | $488M | 1,227,993 | Trimmed |
| Hilton WorldwideHLT | 1.03% | $456M | 1,381,224 | Trimmed |
| SynopsysSNPS | 0.97% | $429M | 961,706 | Added |
| Quest DiagnosticsDGX | 0.90% | $400M | 1,888,207 | Added |
| Asml Hldg Nv | 0.68% | $302M | 151,987 | Held |
| Tradeweb MarketsTW | 0.60% | $265M | 2,663,518 | Added |
| Toronto Dominion BankTD | 0.47% | $210M | 1,731,101 | Trimmed |
| GlaxoSmithKlineGSK | 0.42% | $189M | 3,599,521 | Added |
| Deutsche Bk Ag | 0.40% | $179M | 5,288,878 | Held |
| Rio TintoRIO | 0.39% | $175M | 1,839,135 | Trimmed |
| AramarkARMK | 0.37% | $165M | 2,893,600 | Trimmed |
| Taiwan Semiconductor ManufacturingTSM | 0.35% | $157M | 329,546 | Trimmed |
| Philip Morris InternationalPM | 0.32% | $140M | 775,917 | New |
| Procter & GamblePG | 0.31% | $137M | 936,608 | Added |
| Vodafone Group Plc | 0.30% | $133M | 10,061,670 | Held |
| Darling IngredientsDAR | 0.28% | $126M | 2,300,482 | Trimmed |
| AlbemarleALB | 0.27% | $121M | 897,013 | Trimmed |
| TotalEnergiesTTE | 0.27% | $121M | 1,555,564 | Added |
| Bank of Nova ScotiaBNS | 0.27% | $120M | 1,381,602 | Added |
| Sociedad Quimica y Minera de Chile SA ADR BSQM | 0.27% | $119M | 1,612,070 | Trimmed |
| SunrunRUN | 0.24% | $107M | 8,004,682 | Added |
| GE AerospaceGE | 0.24% | $105M | 279,787 | Trimmed |
By sector
Share of the reported value.
Reported value over time
Total 13F value at each quarter end.
Questions
What stocks does Jeremy Grantham own?
In the Q2 2026 13F, GMO reported 661 US stock positions worth $44.4B. The largest: Microsoft (MSFT) 5.7%, Lam Research (LRCX) 5.3%, Alphabet (GOOGL) 4.9%, Apple (AAPL) 4.5%, Meta Platforms (META) 4.4%.
What did Jeremy Grantham buy last quarter?
In Q2 2026: new position in Philip Morris International (PM); new position in Qorvo (QRVO); new position in Allied Gold (AAUC); added to Microsoft (MSFT); added to Meta Platforms (META); added to Thermo Fisher Scientific (TMO).
What did Jeremy Grantham sell last quarter?
In Q2 2026: cut Lam Research (LRCX); cut Alphabet (GOOGL); cut Apple (AAPL).
When is Jeremy Grantham's next 13F?
13F filings are due 45 days after each quarter ends. The Q3 2026 filing is due by November 14, 2026.
More investors
13F filings list US-listed long positions (and some options) held at quarter end. They leave out short positions, cash, bonds and non-US holdings, and arrive up to 45 days after the quarter ends, so the investor may have traded since. Information only, not investment advice.